Home › Funds › Deep Track Capital, LP › IONS

Deep Track Capital, LP position in IONS

IONIS PHARMACEUTICALS INC · Health Care

Deep Track Capital, LP reported holding 2,200,000 shares of IONS (IONIS PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$174.4M, representing 2.60% of its reported portfolio and ranking #15 among its reported holdings. Deep Track Capital, LP has disclosed IONS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)2.20M sh
Reported value held$174.44M
Portfolio Weight2.60%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Deep Track Capital, LP's IONS position evolved

Deep Track Capital, LP first disclosed a stake in IONS in Q3 2023 at 2,834,069 shares (US$128.6M). The position peaked in Q3 2025 at 3,808,144 shares, worth US$249.1M. Across 12 filings, Deep Track Capital, LP increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,200,000 shares valued at US$174.4M — an increase of 250,000 shares quarter over quarter.. Notable position changes include a 56% trim in Q4 2023 (shares fell 14% over the following quarter), a 136% increase in Q1 2025 (shares rose 31% over the following quarter), a 55% trim in Q4 2025 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.83M $128.55M New
Q4 2023 1.25M $63.19M Reduce
Q1 2024 1.37M $59.54M Add
Q2 2024 2.00M $95.32M Add
Q3 2024 2.20M $88.13M Add
Q4 2024 1.93M $67.61M Reduce
Q1 2025 4.56M $137.70M Add
Q2 2025 4.89M $193.26M Add
Q3 2025 3.81M $249.13M Reduce
Q4 2025 1.70M $134.49M Reduce
Q1 2026 1.95M $146.43M Add
Q2 2026 2.20M $174.44M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IONS and 13F data

IONS (IONIS PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in IONS — the largest reported positions include Two Sigma Investments (US$495.7M), TWO SIGMA ADVISERS, LP (US$241.5M), Tweedy, Browne Co LLC (US$180.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IONS

All IONS fund holders →

FAQ

How long has Deep Track Capital, LP held IONS?

Deep Track Capital, LP has disclosed IONS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Deep Track Capital, LP's current position in IONS?

As of Q2 2026, Deep Track Capital, LP holds 2.20M shares of IONS (IONIS PHARMACEUTICALS INC), valued at $174.44M, representing 2.60% of its reported portfolio and ranking #15.

Has Deep Track Capital, LP been buying or selling IONS?

In the latest 13F filing (Q2 2026), Deep Track Capital, LP increased its position in IONS. The position peaked in Q3 2025 at 3.81M shares.

Which other funds hold IONS?

Other major institutional holders of IONS include Two Sigma Investments, TWO SIGMA ADVISERS, LP, Tweedy, Browne Co LLC, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.